Skip to content

Comparison of the incidence of intraoperative hypoxia between esketamine and sufentanil combined with propofol in elderly patients undergoing urologic surgery under non-intubated general anesthesia

Comparison of the incidence of intraoperative hypoxia between esketamine and sufentanil combined with propofol in elderly patients undergoing urologic surgery under non-intubated general anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077170
Enrollment
Unknown
Registered
2023-11-01
Start date
2023-11-10
Completion date
Unknown
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases of urinary system

Interventions

Esketamine group (Part 1: 25 cases/Part 2: 47 cases):Esketamine (0.25mg /kg), slowly intravenous propofol infusion after 30 seconds (1.5mg /kg, slowly completed within 30s-1min)
Sufentanil group (Part 1: 25 cases/Part 2: 47 cases):Sufen (0.1 µg/kg), slowly intravenous propofol infusion after 30 seconds (1.5 mg/kg, slowly administered within 30s to 1min)

Sponsors

Beijing Friendship Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Body Mass index (BMI) 18-28 kg/m^2; 2. Patients undergoing transurethral electrotomy or transurethral ureteroscopy ureteral laser lithotripsy for bladder lesions under non-tracheal intubation intravenous general anesthesia; 3. Age >=60 years old; 4. Male; 5. ASA grade I-III; 6. The estimated operation time is less than 60 minutes; 7. Sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Allergic to planned medication; 2. Severe liver and kidney dysfunction, abnormal coagulation function; 3. History of irregular hypertension or malignant hypertension; 4. Patients with severe circulatory diseases; 5. Patients with acute respiratory infections and other severe respiratory diseases such as asthma; 6. Preoperative neurological disease, mental illness or previous cognitive impairment; 7. Patients with elevated intracranial and intraocular pressure; 8. The researchers believe that patients who are not suitable to participate in this study.

Design outcomes

Primary

MeasureTime frame
Hypoxic incidence;Propofol ED50 ;

Secondary

MeasureTime frame
MAP HR;Respiration rate;Propofol dosage;Vasoactive drug dosage;Incidence of perioperative adverse reactions;SpO2;

Countries

China

Contacts

Public ContactAn Lixin

Beijing Friendship Hospital, Capital Medical University

anlixin8120@163.com+86 138 1024 8120

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026